Streetbeat News

Stock Prices

GILT

Gilat Satellite Networks reported a year-over-year increase in Q2 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:54 pm

COMP

Compass reported worse-than-expected Q2 financial results and issued Q3 revenue guidance, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:52 pm

CEIX

CONSOL Energy reported a Q2 earnings beat, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 4:50 pm

AHCO

AdaptHealth reported better-than-expected Q2 revenue results and issued FY23 net revenue guidance above estimates, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:47 pm

BLK

A significant amount of unusual options activity has been observed for BlackRock (NYSE:BLK), with a majority of investors taking a bearish stance. Of the 16 strange trades detected, 56% were bearish and 43% bullish. The total amount for puts was $840,158 and for calls was $76,490. Whales have been targeting a price range from $270.0 to $730.0 for BlackRock over the last 3 months. The stock is currently down 2.6% at $694.0. Several financial institutions have maintained their positive ratings on BlackRock, with price targets ranging from $785 to $888.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 4:46 pm

NOVT

Novanta's shares are trading lower due to the company's weak financial guidance for the fiscal year 2023.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 4:43 pm

SWAV

ShockWave Medical reported mixed Q2 results, leading to a decrease in its share price.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 4:42 pm

BWMN

Bowman Consulting Group reported worse-than-expected Q2 EPS results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 4:41 pm

INVH

CNBC's Josh Brown mentioned Invitation Homes (INVH) in a recent segment, causing a spike in the company's share prices.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 4:41 pm

CRSP

CRISPR Therapeutics reported better-than-expected Q2 results, leading to a rise in its share prices.

Portfolio Pulse from Bill Haddad

August 08, 2023 | 4:40 pm